Driving Drug Development for Hematologic Diseases

Relationships That Fuel Research

Our mobile, direct-to-patient approach gives you access to the difficult-to-reach populations affected by these debilitating disorders. You’ll get an all-inclusive view of each patient in your study-meaning you’ll collect more accurate data points related to the complex differences seen on an individual level. Moreover, Sanguine’s emphasis on establishing trust ensures long-term patient participation and study completion.

  • Amyloidosis
  • Idiopathic Thrombocytopenic Purpura (ITP)
  • Sickle Cell Disease (SCD)
  • Thrombotic Thrombocytopenic Purpura (TTP)

Sanguine's Expertise in Hematology


Patient Members


Studies Completed


Contact us to discuss your research needs

Sanguine Services

  • Genotype
  • Blood Type
  • Family History
  • Hospitalization status
  • No treatment
  • Disease Confirmation
  • Covid-19 (PCR)
  • Sickle Cell
  • HIV/HPV/Hepatitis/Herpes Etc.
  • BioMarker Quantification
  • CBC, Platelett, & Diff
  • CRP
  • Cal-Protecin
  • ANA
  • Cytokine Panel
  • BUN
  • Urinalysis
  • Thyroid Stimulating Hormone
  • Lipid Panel
  • LDH
  • Genetic Analysis
  • HLA Typing
  • dsDNA
  • RNA Vial Load Quantification
  • HBV Genotyping
  • Vaso-occlusive crisis (VOC) events (Sickle cell disease)
  • Longitudinal
  • Sickle cell disease studies - exclude disease-modifying therapies

Other Services

Disease State & Healthy Leukopaks
Human PBMCs
Human Serum and Plasma
Employer Onsite Collection Programs
Lymphocyte Isolation
Noninvasive Skin Tapes
PBMCs Isolation Services for Clinical Trials
Longitudinal Sampling & Event-Based Collection